Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.
포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.
터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
IMI announces three new skin sterol patents TORONTO, June 21 /PRNewswire-FirstCall/ -- Leading predictive medicine company IMI International...
Skin sterol correlates with presence of coronary calcium Simple, non-invasive test an effective tool to identify early heart disease TORONTO, June...
IMI plans change in name to PreMD Inc. New name reflects evolution of company from development-stage biotech to innovator in predictive medicine...
New skin sterol data to be presented at American Association for Clinical Chemistry meeting TORONTO, May 24 /PRNewswire-FirstCall/ -- Predictive...
IMI announces first quarter financial results and provides operational update - Lead cardiovascular test, PREVU(x) POC, made available for sale...
PREVU(x) study to open new markets PREVU(x) LT Skin Sterol Test included in 25,000-participant insurance industry study TORONTO, May 10...
IMI announces pivotal breast cancer test study Non-invasive, painless test designed to screen for early-stage disease TORONTO, May 4...
Skin sterol provides new information about heart disease risk PREVU(x) POC Skin Sterol Test has value in further stratifying intermediate-risk...
IMI announces fiscal 2004 financial results TORONTO, March 31 /PRNewswire-FirstCall/ -- IMI International Medical Innovations Inc. (TSX: IMI;...
IMI Announces First Acceptance of Patent for Color Measurement Process Technology used in PREVU(x) Skin Sterol Test as well as cancer products...
IMI provides operational update and previews fiscal 2004 results - Significantly advanced commercialization of PREVU(x) Skin Sterol Test...
IMI announces fiscal 2004 update conference call & webcast TORONTO, March 7 /PRNewswire-FirstCall/ -- IMI International Medical Innovations Inc...
Growing evidence that skin sterol is linked to hidden heart disease Simple, non-invasive test reveals coronary artery disease in patients with...
IMI files patent application for new format of skin sterol technology TORONTO, March 1 /PRNewswire-FirstCall/ -- IMI International...
IMI provides update on ARISE clinical trial TORONTO, Feb. 28 /PRNewswire-FirstCall/ -- Amendments approved last week by the U.S. Food and Drug...
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관